Thomas D L, Quinn T C
Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Infect Dis Clin North Am. 1993 Dec;7(4):793-824.
This article addresses current issues regarding serologic testing for selected STDs, particularly those for which serologic testing has been useful for diagnosis, monitoring therapy, or seroepidemiology. For each selected pathogen, the authors discuss the strengths and weaknesses of the serologic tests as diagnostic assays, as measures of disease incidence and relevance, and as prospective markers identifying risk alterations in a given population. Also, for some conditions such as syphilis, the usefulness of serology as a measure of therapy or success of disease intervention is briefly outlined.
本文讨论了当前关于特定性传播疾病血清学检测的问题，特别是那些血清学检测对诊断、治疗监测或血清流行病学有用的疾病。对于每种选定的病原体，作者讨论了血清学检测作为诊断试验、疾病发病率和相关性测量方法以及识别特定人群风险变化的前瞻性标志物的优缺点。此外，对于梅毒等一些疾病，还简要概述了血清学作为治疗措施或疾病干预成功与否的衡量指标的实用性。
